RXRX vs CNO-P-A
Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and CNO Financial Group Inc (CNO-P-A, Company).
5-Year PerformanceCNO-P-A has outperformed RXRX, delivering a return of -3.3% compared to -35.3%
RXRX vs CNO-P-A - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
RXRX vs CNO-P-A - Historical Returns
Returns include dividend reinvestment.
RXRX vs CNO-P-A - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | RXRX | CNO-P-A |
|---|---|---|
| 2026 | -23.33% | -8.17% |
| 2025 | -43.27% | +4.18% |
| 2024 | -31.51% | +17.33% |
| 2023 | +30.60% | +11.87% |
| 2022 | -57.24% | -31.93% |
| 2021 | -45.27% | +2.43% |
| 2020 | N/A | +0.11% |
RXRX vs CNO-P-A Drawdown Comparison
The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for CNO-P-A was -41.49%, occurring on May 4, 2023. This drawdown has not yet recovered.
The current RXRX drawdown is -92.21%. The current CNO-P-A drawdown is -16.23%.
| Rank | RXRX | CNO-P-A |
|---|---|---|
| #1 | -93.13% Jul 13, 2021 - Mar 30, 2026 | -41.49% Jul 7, 2021 - May 4, 2023 |
| #2 | -38.10% Apr 29, 2021 - Jun 17, 2021 | -7.90% Dec 21, 2020 - Jun 22, 2021 |
| #3 | -10.54% Apr 16, 2021 - Apr 21, 2021 | -1.26% Nov 30, 2020 - Dec 16, 2020 |
| #4 | -10.45% Jun 21, 2021 - Jul 6, 2021 | -0.11% Jun 24, 2021 - Jun 30, 2021 |
| #5 | -8.29% Apr 21, 2021 - Apr 29, 2021 | N/A |
Correlation
Correlation between RXRX and CNO-P-A is 0.30 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks